Logo

AUNA

Auna S.A.

AUNA

Auna S.A. • NYSE
$4.63 ▼ -3.14% (-0.15)
Market Cap $342.82 M
52w High $9.24
52w Low $4.60
Dividend Yield 0%
P/E 4.72
Volume 199.61K
Outstanding Shares 74.04M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.094B ▲ $258.93M ▼ $47.094M ▼ 4.306% ▼ $0.65 ▼ $261.334M ▼
Q2-2025 $1.062B ▲ $262.186M ▲ $79.581M ▲ 7.494% ▲ $1.11 ▲ $296.513M ▲
Q1-2025 $993.684M ▼ $240.068M ▼ $33.788M ▲ 3.4% ▲ $0.48 ▲ $224.483M ▲
Q4-2024 $1.067B ▼ $256.828M ▼ $22.038M ▼ 2.066% ▼ $0.3 ▼ $218.126M ▼
Q3-2024 $1.117B $272.621M $97.092M 8.689% $1.32 $315.455M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $325.398M ▲ $7.282B ▲ $5.467B ▲ $1.658B ▲
Q2-2025 $287.106M ▼ $7.167B ▲ $5.371B ▼ $1.643B ▲
Q1-2025 $298.784M ▼ $7.07B ▼ $5.399B ▼ $1.519B ▲
Q4-2024 $335.973M ▲ $7.081B ▼ $5.458B ▼ $1.477B ▼
Q3-2024 $298.517M $7.15B $5.481B $1.519B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $48.094M ▼ $188.555M ▲ $-10.196M ▲ $-127.41M ▲ $51.049M ▲ $170.107M ▲
Q2-2025 $84.022M ▲ $145.208M ▲ $-45.02M ▲ $-130.96M ▼ $-26.356M ▲ $111.685M ▲
Q1-2025 $37.963M ▲ $106.015M ▼ $-63.689M ▲ $-77.833M ▲ $-34.728M ▼ $57.244M ▼
Q4-2024 $23.857M ▼ $193.546M ▼ $-64.107M ▼ $-90.148M ▲ $35.252M ▼ $160.702M ▼
Q3-2024 $100.513M $203.558M $-56.763M $-95.778M $42.764M $167.554M

Five-Year Company Overview

Income Statement

Income Statement Auna’s income statement shows a fast-growing healthcare platform that has finally turned the corner into profitability after several years of losses. Revenue has climbed steadily each year, and profits before financing costs have grown faster than sales, suggesting improving efficiency and good operating leverage. Gross and operating margins have both expanded, meaning the company is keeping more of each unit of revenue as it scales. However, bottom-line net profit is still relatively slim compared with the size and growth of the business, and past losses highlight that earnings can be volatile as the company invests and expands. Overall, the trend is clearly positive, but the earnings base is still in an early, building phase rather than a mature, stable profile.

Balance Sheet

Balance Sheet The balance sheet reflects a company that has expanded aggressively and now carries a meaningful amount of debt. Total assets have grown substantially over the period, indicating investment in hospitals, clinics, and related healthcare infrastructure. Equity has also increased, showing that retained earnings and possibly past capital infusions are supporting growth. However, debt remains high relative to both equity and cash, which increases financial risk and makes the company more sensitive to interest costs and refinancing conditions. Cash on hand is modest for a business of this size, which underlines the importance of maintaining strong, consistent cash generation to support operations and future investments.

Cash Flow

Cash Flow Cash flows are a relative bright spot. Operating cash flow has been steadily positive and has grown as the business has scaled, indicating that the core operations are generating real cash, not just accounting profits. Free cash flow has shifted from roughly breakeven to consistently positive, even while the company continues to invest in its asset base. Capital spending remains significant but is becoming more manageable relative to the cash the business produces. This pattern suggests the heaviest part of the investment cycle may be easing, although expansion plans in newer markets could still demand substantial cash in the future.

Competitive Edge

Competitive Edge Auna occupies a differentiated position in Latin American healthcare by combining hospitals, clinics, and its own health plans within a single integrated ecosystem. This vertical integration can improve care coordination, control costs, and deepen relationships with patients, especially in complex specialties like oncology and cardiology. Its focus on high-complexity care builds strong clinical expertise and reputation in areas that are harder for new entrants to replicate. Operating in under-served markets such as Peru, Colombia, and Mexico provides a long runway for demand growth, but also exposes the company to regulatory changes, political risk, and macroeconomic volatility. Execution in Mexico, where the company is still in a recovery and build-out phase, is especially important to its long-term competitive standing.

Innovation and R&D

Innovation and R&D Innovation is a central part of Auna’s strategy. The proprietary “AunaWay” operating model aims to standardize high-quality care and drive efficiency across markets, which can be a powerful intangible asset if consistently applied. Through its “Auna Ideas” arm, the company is experimenting with home hospitalization, new digital tools for patient engagement, and the use of artificial intelligence to streamline internal processes. Its emphasis on oncology is supported by specialized centers of excellence, research collaborations, and newly designed insurance products that tie coverage closely to its care network. Partnerships with technology platforms and global investors add further innovation capacity. The main risk is execution: integrating new technology, rolling out new models across countries, and scaling research efforts all take time, capital, and strong management discipline.

Summary

Auna looks like a rapidly scaling Latin American healthcare platform that is transitioning from a heavy investment phase into a more balanced period of growth and profitability. The business has moved from losses to modest profits, with improving margins and strengthening cash generation, although past volatility and high leverage remain important considerations. Its integrated model, focus on complex care, and structured operating playbook provide a clear strategic identity and potential moat in under-served markets. At the same time, the company is carrying substantial debt, operates with relatively limited cash buffers, and is executing ambitious expansion plans, particularly in Mexico, which heightens execution and financial risk. Innovation and partnerships add upside potential but also increase complexity. Overall, Auna combines attractive strategic positioning with a still-evolving financial profile, where future performance will depend heavily on disciplined growth, cost control, and successful delivery of its expansion and digital transformation plans.

NEWS

November 20, 2025 · 4:45 PM UTC

Auna Announces 3Q25 Financial Results

Read more

November 20, 2025 · 4:30 PM UTC

Auna Announces Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America

Read more

November 18, 2025 · 9:25 AM UTC

Construction License for Torre Trecca Is Granted to EsSalud, Marking Key Milestone in Auna's Public–Private Partnership with the Institution

Read more

November 7, 2025 · 8:40 AM UTC

Auna Announces Completion of US$765 million Debt Refinancing

Read more

November 4, 2025 · 12:24 AM UTC

Auna Announces Successful Pricing of 8.750% Senior Secured Notes Due 2032

Read more